Regencell Bioscience Holdings Ltd (RGC)

5.00 -0.33 (-6.19%) USD  |  NASDAQ  |  Dec 16, 16:00
5.00 0.00 (0.00%) After-Hours: 19:33
More

Regencell Bioscience Holdings Enterprise Value: 61.40M for Dec. 13, 2024

Enterprise Value Chart

View Enterprise Value for RGC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Sino Biopharmaceutical Ltd 8.491B
HUTCHMED (China) Ltd 1.954B
Pharmaron Beijing Co Ltd --
Prenetics Global Ltd 31.16M
Uni-Bio Science Group Ltd 13.51M

Enterprise Value Related Metrics

Earnings Yield -6.60%